BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10896833)

  • 1. The high level of hCDC10 gene expression in neuroblastoma may be associated with favorable characteristics of the tumor.
    Nagata T; Takahashi Y; Asai S; Ishii Y; Mugishima H; Suzuki T; Chin M; Harada K; Koshinaga S; Ishikawa K
    J Surg Res; 2000 Aug; 92(2):267-75. PubMed ID: 10896833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
    Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B
    Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
    N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
    Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
    J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide.
    Orlando C; Raggi CC; Bagnoni L; Sestini R; Briganti V; La Cava G; Bernini G; Tonini GP; Pazzagli M; Serio M; Maggi M
    Med Pediatr Oncol; 2001 Jan; 36(1):224-6. PubMed ID: 11464890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characteristics of mediastinal neuroblastoma.
    Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Tasaka H; Yano H; Akiyama H; Ikeda K
    Eur J Pediatr Surg; 2000 Dec; 10(6):353-9. PubMed ID: 11215774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta, is associated with favorable prognosis in human neuroblastomas.
    Kawamoto T; Ohira M; Hamano S; Hori T; Nakagawara A
    Int J Oncol; 2003 Apr; 22(4):815-22. PubMed ID: 12632073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
    Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
    Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
    J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
    Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM
    Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma.
    de Souza DR; Sanabani SS; de Souza AC; Filho Odone V; Epelman S; Bendit I
    Pediatr Blood Cancer; 2011 May; 56(5):749-56. PubMed ID: 21154590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis.
    Rydén M; Sehgal R; Dominici C; Schilling FH; Ibáñez CF; Kogner P
    Br J Cancer; 1996 Sep; 74(5):773-9. PubMed ID: 8795581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression of neuronal nitric oxide synthase and adrenomedullin in human neuroblastoma using real-time PCR.
    Dötsch J; Harmjanz A; Christiansen H; Hänze J; Lampert F; Rascher W
    Int J Cancer; 2000 Oct; 88(2):172-5. PubMed ID: 11004664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of N-myc messenger RNA in neuroblastomas found by mass screening.
    Matsunaga T; Shirasawa H; Hishiki T; Yoshida H; Kouchi K; Ohtsuka Y; Kawamura K; Etoh T; Ohnuma N
    Clin Cancer Res; 2000 Aug; 6(8):3199-204. PubMed ID: 10955804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic discrimination among neuroblastomas according to Ha-ras/trk A gene expression: a comparison of the profiles of neuroblastomas detected clinically and those detected through mass screening.
    Tanaka T; Sugimoto T; Sawada T
    Cancer; 1998 Oct; 83(8):1626-33. PubMed ID: 9781958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
    Nakagawa A; Matsuoka K; Okita H; Iwafuchi H; Hori H; Kumagai M
    Pediatr Dev Pathol; 2011; 14(2):87-92. PubMed ID: 21288077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYCN protein expression as a predictor of neuroblastoma prognosis.
    Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
    Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis--a study of 106 primary neuroblastomas treated in a single institute.
    Hishiki T; Saito T; Terui K; Sato Y; Takenouchi A; Yahata E; Ono S; Nakagawara A; Kamijo T; Nakamura Y; Matsunaga T; Yoshida H
    J Pediatr Surg; 2010 Dec; 45(12):2293-8. PubMed ID: 21129533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The studies on the correlation for gene expression of tyrosine-kinase receptors and vascular endothelial growth factor in human neuroblastomas.
    Zhang J; Zheng Y; Wang Y; Tong H
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):180-4. PubMed ID: 20186105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.
    Combaret V; Gross N; Lasset C; Frappaz D; Peruisseau G; Philip T; Beck D; Favrot MC
    J Clin Oncol; 1996 Jan; 14(1):25-34. PubMed ID: 8558206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.